Insider trading

Period: 12 months Type of trade: Sold × Share of holding: 50% or more × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

5,123 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

5,123 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

5,123 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

5,123 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
5,123 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
5,123 decisions over 12 months Remove this filter
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

5,123 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
21 Oct 2025
WILLIAMS ROBERT M JR 10% owner · indirect
Sold at will 3×
$90.00M 10,000,000 at 9.00
96.3%
Sold half or more
21 Oct 2025
Bhatt Baiju Director · indirect
Sold on a plan 4×
$55.68M 418,338 at 133.11
100%
Sold half or more
21 Oct 2025
Sold at will
$11.07M 4,000,000 at 2.77
62.7%
Sold half or more
21 Oct 2025
Bicket John SEE REMARKS · indirect
Sold on a plan 7×
$6.57M 170,000 at 38.66
85.0%
Sold half or more
21 Oct 2025
Biswas Sanjit CHIEF EXECUTVE OFFICER · indirect
Sold on a plan 7×
$6.18M 160,000 at 38.63
84.2%
Sold half or more
21 Oct 2025
ROTHBLATT MARTINE A Chairperson & CEO
Sold on a plan 4×
$1.71M 4,000 at 427.76
96.9%
Sold half or more
21 Oct 2025
Willett Robert Director
Sold at will
$331.89K 6,704 at 49.51
100%
Sold half or more
21 Oct 2025
Yezhkov Sergey SVP/Co-Head of Global Business
Sold at will
$227.06K 1,511 at 150.27
91.2%
Sold half or more
21 Oct 2025
D'Amico Andrew Director
Sold on a plan
$68.00K 1,000 at 68.00
100%
Sold half or more
20 Oct 2025
Lord Rachel Senior Managing Director
Sold at will 9×
$13.98M 12,000 at 1,165.04
62.5%
Sold half or more
20 Oct 2025
BENKOWITZ MICHAEL PRESIDENT AND COO · indirect
Sold on a plan 2×
$9.62M 22,500 at 427.41
100%
Sold half or more
20 Oct 2025
Patel Sanj K CHAIRMAN & CEO
Sold on a plan 2×
$4.72M 121,248 at 38.90
52.0%
Sold half or more
20 Oct 2025
Hacker Severin Chief Tech Officer, Co-Founder
Sold on a plan 15×
$3.15M 10,000 at 314.72
99.3%
Sold half or more
20 Oct 2025
RA CAPITAL MANAGEMENT, L.P. Director · indirect
Sold at will 4×
$2.73M 92,023 at 29.67
100%
Sold half or more
20 Oct 2025
Megna Michael R CHIEF ACCOUNTING OFFICER
Sold on a plan 2×
$1.96M 50,490 at 38.87
65.1%
Sold half or more
20 Oct 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN · indirect
Sold on a plan
$1.90M 10,000 at 190.00
66.7%
Sold half or more
20 Oct 2025
ROTHBLATT MARTINE A Chairperson & CEO
Sold on a plan 5×
$1.70M 4,000 at 424.59
96.9%
Sold half or more
20 Oct 2025
Moreadith Randall Chief Scientific Officer
Sold on a plan
$32.29K 6,500 at 4.97
100%
Sold half or more
17 Oct 2025
Daniele Philip B. President & CEO
Sold at will 10×
$10.18M 2,533 at 4,020.88
97.9%
Sold half or more
17 Oct 2025
RA CAPITAL MANAGEMENT, L.P. Director · indirect
Sold at will 6×
$7.67M 260,859 at 29.39
94.5%
Sold half or more
17 Oct 2025
Duda Kenneth President and CTO
Sold on a plan 5×
$4.28M 30,000 at 142.75
69.8%
Sold half or more
17 Oct 2025
REED JOHN C EVP, Innovative Medicine, R&D
Sold at will
$4.19M 21,721 at 192.71
67.1%
Sold half or more
17 Oct 2025
ROTHBLATT MARTINE A Chairperson & CEO
Sold on a plan 2×
$1.72M 4,000 at 430.67
96.9%
Sold half or more
Showing 5,101–5,123 of 5,123. ← Newer Page 103 of 103